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ABSTRACT
Background: Excessive diagnostic testing and defensive medicine contribute to billions of dollars in avoidable
costs in the United States annually. Our objective was to determine the influence of financial incentives,
accompanied with information regarding test risk and benefit, on patient preference for diagnostic testing.
Methods: We conducted a cross-sectional survey of patients at the University of Michigan emergency
department (ED). Each participant was presented with a hypothetical scenario involving an ED visit following
minor traumatic brain injury. Participants were given information regarding potential benefit (detecting brain
hemorrhage) and risk (developing cancer) of head computed tomography scan, as well as an incentive of $0 or
$100 to forego testing. We used 0.1 and 1% for test benefit and risk, and values for risk, benefit, and financial
incentive varied across participants. Our primary outcome was patient preference to undergo testing. We also
collected demographic and numeracy information. We then used logistic regression to estimate odds ratios (ORs),
which were adjusted for multiple potential confounders. Our sample size was designed to find at least 300 events
(preference for testing) to allow for inclusion of up to 30 covariates in fully adjusted models. We had 85% to 90%
power to detect a 10% absolute difference in testing rate across groups, assuming a 95% significance level.
Results: We surveyed 913 patients. Increasing test benefit from 0.1% to 1% significantly increased test
acceptance (adjusted OR [AOR] = 1.6, 95% confidence interval [CI] = 1.2 to 2.1) and increasing test risk from
0.1% to 1% significantly decreased test acceptance (AOR = 0.70, 95% CI = 0.52 to 0.93). Finally, a $100
incentive to forego low-value testing significantly reduced test acceptance (AOR = 0.6; 95% CI = 0.4 to 0.8).
Conclusions: Providing financial incentives to forego testing significantly decreased patient preference for
testing, even when accounting for test benefit and risk. This work is preliminary and hypothetical and requires
confirmation in larger patient cohorts facing these actual decisions.
Excessive unnecessary diagnostic testing incurstremendous costs to the health care system. With
estimated total defensive medicine costs reaching $46
billion in the United States in 2008 alone, reducing
the amount of unnecessary diagnostic tests is critical to
mitigating rising health care costs.1 Head computed
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tomography (CT) scans are diagnostic tests that pro-
vide significant clinical utility when indicated, but they
are often used against established clinical guidelines
in situations of minor injury. Previous reports suggest
that one-third of head CT scans are avoidable by
applying the Canadian CT Head Rule.2 Furthermore,
head CT scans expose patients to harmful radiation
that is linked to an increased cancer risk.3
An evidence-based medicine approach is useful for
avoiding diagnostic testing that is unlikely to benefit
patients; however, determining what constitutes a low-
value test is challenging, as the value of a given test can
vary across individual patients.4 Factors such as low
health literacy, cultural power imbalances, or detach-
ment from the medical decision-making process can all
contribute to patients’ hesitancy to make their concerns
about testing known.4,5 Nevertheless, it is important to
engage patients to consider the benefits and risks of
diagnostic testing, particularly when a test may be of low
clinical value. Previous work performed by the authors
of this study suggests that, when presented with a hypo-
thetical scenario of minor traumatic brain injury (mTBI)
and asked for their preferences regarding pursuing a
diagnostic head CT scan, patients were most strongly
deterred by increasing personal financial test cost.6,7
This study seeks to examine the effect, if any,
that a direct financial incentive to forego a low-value
diagnostic head CT scan has on patients’ prefer-
ences to undergo testing in a hypothetical mTBI sce-
nario where numerical information regarding test
benefit and risk is also provided. While there is evi-
dence to suggest that patients are financially moti-
vated when making decisions regarding their medical
care, how patients respond to payments incentivizing
healthy behaviors and decisions remains highly con-
troversial.6–10 We hypothesized, consistent with the
results of our previous study, that patients will be
significantly deterred from accepting a low-value head
CT scan when a financial incentive to forego low-
value testing is applied, whereas test risk and benefit
will not have a statistically significant effect.7
METHODS
Overview
This is a cross-sectional survey of a convenience
sample of patients from the University of Michigan
emergency department (ED) exploring the effect that
varying levels of benefit, risk, and financial
incentives associated with diagnostic testing have on
patients’ willingness to undergo testing.
Study Design
We presented participants with a hypothetical clinical
scenario in which they presented to the ED following
mTBI. The full scenario can be found in Data Supple-
ment S1 (available as supporting information in the
online version of this paper, which is available at http://
onlinelibrary.wiley.com/doi/10.1111/acem.13823/
full). The scenarios represented low-risk injury that
would not indicate obtaining a head CT scan on the
basis of the Canadian CT Head Rule. Each participant
also was presented with a chest pain scenario, which will
be reported in a separate scientific report. The order of
receiving the chest pain or mTBI scenario was random-
ized, and the participants received a distinct random set
of benefits, risks, and incentives for each scenario.
After consent was obtained, a script of the scenario
was read aloud to all participants to limit possible
issues they might have with reading, seeing, or com-
prehending the scenario. Participants were then asked
if they would elect to receive a diagnostic head CT
scan, given different levels of benefit (the chance that
the head CT scan accurately detects a life-threatening
brain hemorrhage), risk (the chance of developing can-
cer within 10 years due to ionizing radiation from the
head CT scan), and incentive (a cash payment from
their insurance company to forego low-value testing).
Each participant was randomly assigned a value for
benefit (0.1% or 1%), risk (0.1% or 1%), and incentive
($0 or $100) associated with a head CT scan. Partici-
pants were provided with percentages (0.1% or 1%),
ratios (one in 100 or one in 1000), and visual depic-
tions (Data Supplement S1) of risk and benefit values
to improve comprehension.11,12 These values were pre-
viously used in an earlier study performed by the
authors and were originally selected based on a separate
preliminary study performed by the authors, as these val-
ues for risk, benefit, and cost were thought to represent
the most interesting zone of variation in patients’ prefer-
ences for diagnostic testing.6,7 Additionally, values of
0.1 and 1% represent plausible benefit and risk proba-
bilities associated with diagnostic head CT scans follow-
ing situations of minor head trauma.13
Setting and Population
The population for this study was a convenience sample
of patients at the University of Michigan ED. We
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recruited 913 total patients age 18 or older between May
and July 2016. Patients who were presenting with chest
pain, recent head trauma, or altered mental status were
not approached. We did not approach patients with
contact precautions or in resuscitation bays. Participants
were not offered any compensation for participating in
our study, and participation was completely voluntary.
Human Subjects Protection
The University of Michigan Institutional Review
Board reviewed this study and determined it to be
exempt survey research.
Primary Outcomes and Variables
The primary outcome for this study was the percentage
of patients electing to receive a head CT scan given
three major predictive variables: benefit, risk, and
financial incentive. There were eight total subgroups
of respondents, given that each of these three variables
had two possible values.
We collected the following deidentified demographic
and medical information to assess for potential con-
founders: age; sex; marital status; educational status;
race; ethnicity; prior medical training or employment;
self-reported overall health; income; and a past medical
history of cancer, hypertension, diabetes, atrial fibrilla-
tion, myocardial infarction, or head trauma requiring
a hospital visit. In addition, we administered a previ-
ously validated numeracy assessment to classify partici-
pants as having low, medium, or high numeracy.14
Data Collection
Qualtrics was used for survey administration and data
collection, and SPSS (Version 25) was used for data
analysis. We included any participant response in
which the primary outcome was collected. We com-
pared the unadjusted proportion of respondents elect-
ing to receive a head CT scan for each combination
of values for benefit, risk, and financial incentive.
Sample Size
We followed the methodology we previously reported
in 2018 in the work focusing on an additional copay-
ment for a diagnostic test.7 Briefly, our sample size of
913 was feasible for our workforce (medical students
conducting summer research) to recruit, and it con-
ferred approximately 85% to 90% power to detect a
10% absolute change in the proportion of subjects
desiring testing from a baseline test acceptance rate of
50% at a 95% level of significance.6
Data Analysis
We next performed a series of nested multivariable
logistic regression models to obtain the odds that par-
ticipants would agree to receive a head CT scan, given
these variable combinations. We selected four sets of
variables to adjust for in the models, and all variables
were specified in advance so that they would be
included regardless of their significance. Sets of vari-
ables were ordered based on what we hypothesized
would be most influential, with potentially more influ-
ential variables incorporated into earlier models. The
fully adjusted model was limited to at most 30 vari-
ables, using a guideline of 10 outcome events per pre-
dictor. Model 1 adjusts for the benefit, risk, and
financial incentive associated with testing. Model 2
additionally adjusts for income, education level, and
numeracy. Model 3 additionally adjusts for age, sex,
race, ethnicity, and previous health care training/em-
ployment. Finally, Model 4 additionally adjusts for
self-reported overall health and a medical history of
cancer, hypertension, diabetes, atrial fibrillation,
myocardial infarction, or head trauma requiring a hos-
pital visit. We evaluated model fit by examining the
Hosmer and Lemeshow goodness-of-fit statistic with a
p-value of >0.05 indicating adequate fit. In accordance
with the instructions for SPSS, we fit linear regression
models with indicator variables to assess for multi-
collinearity, with a variance inflation factor below 10
indicating a lack of meaningful multicollinearity. The
deidentified data set, along with the model output
(which includes all parameter estimates for the fully
adjusted models, goodness of fit statistics, and multi-
collinearity diagnostics) is posted in the University of
Michigan Institutional Data Repository (https://
doi.org/10.7302/pnmm-4v40).
RESULTS
In total, 913 patients met inclusion criteria and com-
pleted the primary outcome portion of the survey. All
of these participants’ results were included in the anal-
ysis. Demographic and medical participant characteris-
tics are displayed in Table 1. The median participant
age for this study was 45 years (interquartile range =
30–60 years), with an absolute range of 18 to 92
years. Patient preferences by group—representing the
eight possible combinations of risk, benefit, and incen-
tive—are shown in Table 2.
Patients elected to receive a head CT scan in 54.2%
of scenarios (495 of 913 surveyed). In the unadjusted
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analysis, decreased benefit, increased risk, and a finan-
cial incentive were all associated with a statistically sig-
nificant decrease in odds of test acceptance (Table 3).
Furthermore, the overall pattern of test acceptance in
each of the adjusted regression models was similar to
the unadjusted analysis in that decreased benefit,
increased risk, and offering a $100 financial incentive
deterred participants from accepting a head CT scan
(Table 4). This similarity suggests that none of the
variables present in model 2, 3, or 4 acted as con-
founders influencing the observed effect of the major
predictive variables on test acceptance.
Fully adjusted models (Table 4) demonstrated that
patients’ odds of accepting a head CT scan was signifi-
cantly lower when offered a $100 incentive to forego
testing versus when there was no incentive (adjusted
OR [AOR] = 0.59, 95% confidence interval [CI] =
0.44–0.79). There was a statistically significant increase
in odds of test acceptance with increasing test benefit
Table 1





















Highest level of education
Some high school 3.9 (36)
High school graduate 15.4 (141)
Some college 31.5 (288)
College graduate 26.4 (241)
Postgraduate 16.1 (147)
Unreported 6.6 (60)
Works in health care 24.5 (224)
Hispanic 5.3 (48)
Race
American Indian/Alaska Native 0.5 (5)
African American 12.0 (110)
Caucasian 77.1 (704)
Asian 2.1 (19)
Native Hawaiian/Pacific Islander 0.2 (2)
Other 2.0 (18)
Prefer not to disclose/unreported 6.0 (55)
History of cancer 13.2 (120)
History of diabetes 15.1 (137)
History of hypertension 29.2 (264)
History of atrial fibrillation 7.7 (70)
History of heart attack 5.0 (45)
History of head injury requiring ED visit 20.5 (184)
Self-reported overall health
Excellent 10.6 (97)
















$200,000 or more 5.4 (49)
Unreported/Prefer not to disclose 39.3 (359)
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from 0.1% to 1% (AOR = 1.58, 95% CI = 1.18–
2.13) and a significant decrease in odds of test accep-
tance with increased test risk from 0.1% to 1%
(AOR = 0.70, 95% CI = 0.52–0.93).
DISCUSSION
Our study examined the effect of test benefit, test risk,
and financial incentives on patient preferences regard-
ing pursuing low-value diagnostic testing with head
CT scan in the ED. In this cross-sectional conve-
nience sample, we found that decreased benefit,
increased risk, and offering a financial incentive all sig-
nificantly deterred participants from accepting low-
value diagnostic testing. These findings are applicable
to both healthcare providers and payers. For example,
these results indicate that discussing benefits and risks
of low-value diagnostic testing via head CT scan with
patients, even when absolute benefit or risk is very
low, may impact patients’ decision-making. Further-
more, implementation of a cash incentive to forego
unnecessary diagnostic testing may prove to be a suc-
cessful method to decrease health care costs for ED
patients. Future studies involving other diagnostic tests
may shed light on the generalizability of this effect
across a variety of clinical situations.
This research was a follow-up to a similar published
study in which we evaluated the influence of benefit,
risk, and out-of-pocket cost on patient preference for
low-value diagnostic testing in the context of mTBI.11
Both of these studies have shown a trend of decreased
test acceptance with decreased test benefit and
increased test risk. Furthermore, both approaches to
financial intervention—increasing cost to patients ver-
sus offering an incentive—were effective in decreasing
test acceptance. In this study, there was a 9.3% drop
in test acceptance (58.9% to 49.6%) with decreased
test benefit, a 10.2% drop (59.3% to 49.1%) with
increased risk, and a 11.7% drop (60.0% to 48.3%)
with a financial incentive. In the 2018 work, a subset
of parents with children received a modified scenario
where they were asked to decide on testing for a child
with mTBI. From this study, in the cohort of adults
deciding on testing for themselves, there was a 6.2%
drop (67.0% to 60.8%) in head CT scan acceptance
with decreased benefit, a 3.0% drop (65.5% to
62.5%) with increased risk, and a 17.4% drop (72.9%
to 55.5%) with increased cost to the patient. However,
in contrast with our current study, the effects of vari-
able test risk and benefit failed to reach statistical sig-
nificance in the prior study, which may be attributable
to variation between the data sets and about a 12%
smaller sample size in the prior work. Examination of
the findings of both studies in parallel suggests that
financial measures may serve as a more effective deter-
rent against patient preference for diagnostic testing
than discussing risks and benefits of testing, although
further investigation is required to better characterize
these effects.
Table 4
Nested Logistic Regression Model*
Model 1 Model 2 Model 3 Model 4
Benefit (1% vs. 0.1%) 1.47 (1.13–1.91) 1.46 (1.10–1.94) 1.48 (1.11–1.98) 1.58 (1.18–2.13)
Risk (1% vs. 0.1%) 0.66 (0.51–0.86) 0.71 (0.53–0.94) 0.70 (0.53–0.93) 0.70 (0.52–0.93)
Incentive ($100 vs $0) 0.64 (0.49–0.82) 0.61 (0.46–0.82) 0.61 (0.46–0.81) 0.59 (0.44–0.79)
Data are reported as AOR (95% CI). Model 1 adjusts for benefit, risk, and incentive associated with testing. Model 2 additionally adjusts
for income, education level, and numeracy. Model 3 additionally adjusts for age, sex, race, ethnicity, and previous health care training or
employment. Model 4 additionally adjusts for self-reported overall health and a medical history of cancer, hypertension, diabetes, atrial fib-
rillation, myocardial infarction, and head trauma requiring hospital visit. Hosmer and Lemeshow goodness-of-fit p-value ranged from 0.8
to 0.2, indicating that model fit was adequate. Variance inflation factors for each included variable ranged from 1 to 1.4 (with values less
than 10 indicating a lack of meaningful multicollinearity).
AOR = adjusted odds ratio.
Table 3
Unadjusted Patient Preferences* (N = 913)
Benefit
0.1% (ref) 49.6 (226)
1% 58.9 (269)
OR (95% CI) 1.471 (1.128–1.917)
Risk
0.1% (ref) 59.3 (271)
1% 49.1 (224)
OR (95% CI) 0.661 (0.507–0.861)
Incentive
$0 (ref) 60.0 (275)
$100 48.3 (220)
OR (95% CI) 0.636 (0.488–0.828)
Total 54.2 (495)
All ORs are unadjusted. Data are reported as percent (n) accept-
ing test.
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LIMITATIONS
Our study has several limitations that should be
taken into consideration while interpreting our
results. Importantly, although participants were
patients in the ED, the survey consisted of hypotheti-
cal scenarios—patients presenting with an acute med-
ical problem may make decisions differently. Also,
the true benefit and risk of a diagnostic test varies
substantially across patients based on their individual
traits and clinical presentations, and it would be unli-
kely that patients could be provided with an exact
numeric representation of their individual test risk
and benefit. Participants in our study may also have
incorporated their own perception of risk for brain
hemorrhage in the context of mTBI, although our
study instructions clearly indicated that participants
should disregard their known medical comorbidities
and that the numeric benefit and risk provided in
the scenario accounted for their specific risk factors.
For example, patients on anticoagulation therapy may
have been told in the past that they should always
receive a diagnostic head CT scan, even in the event
of minor trauma, whereas in our study such patients
could be assigned a 0.1% expected chance of a seri-
ous intracranial injury. Furthermore, in our study we
contrasted the benefit of detecting an immediate med-
ical condition (brain hemorrhage) against the risk of
acquiring another medical condition (cancer) several
years in the future. The difference in time of onset
for benefit and risk may have affected participants’
preferences. In addition, the true risks of CT scans
are likely lower than the 0.1 and 1% assigned in
these scenarios; however, had we used much smaller
risks, we would not have had symmetry with the val-
ues for potential benefit. Another potential limitation
of our study is that 25% of participants reported
working in a healthcare environment. While this
encompassed many professions (full list in Data Sup-
plement S1) and was not unexpected for our usual
ED population, it is possible that increased medical
knowledge or experience could have influenced survey
responses for some of these participants. Finally, the
role of a financial incentive as a deterrent against
diagnostic testing described in this study is restricted
to the survey scenario—a low-risk, low-value test.
Patients may respond differently to a financial incen-
tive applied to another diagnostic test. Factors such
as familiarity with the diagnostic test, perception of
the importance of potential medical conditions that
could be detected, and understanding the implica-
tions of future risk may all influence patient prefer-
ence.
CONCLUSIONS
This cross-sectional survey of patients in the ED sug-
gests that a direct financial incentive is an effective
deterrent against patient preference for low-value diag-
nostic testing in the context of minor traumatic brain
injury. While we also found that decreased potential
benefit and increased risk associated with testing
reduced patient preference for head CT scan, consider-
ation of our results in conjunction with findings in a
previous published work by the authors suggests that
financial factors may be more influential to patients
than estimates of test benefit and risk in scenarios
where testing is considered to be of low value. Further
study of the impact of financial incentives on patient
decision making across other clinical scenarios and in
nonhypothetical patient situations is needed to better
describe this relationship.
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